Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Insulin Archives
Print | Email | Share | Comments (0)

Who Gets That Pancreas? The FDA Wonders, Too

Sep 1, 1995

The Food and Drug Administration is beginning to worry about how to regulate cells and organs for transplant, something that has traditionally been left to doctors to decide.

Up till now, the practice of transplantation has been considered a practice of medicine, something the FDA does not regulate.

"(Organs and cells) are not a product, not a traditional drug," said Dr. Philip Noguchi, chief of gene therapy for the FDA. "The question is when to regulate cells themselves."

The FDA oversees a limited number of cellular transplants-for example, making sure that blood and insulin are safe. But now researchers are testing animal organs in humans (xenotrans-plantation), and the use of cells for injection like medicine. The FDA is now forced to question whether these are things that transcend routine medical practice. And if they are not performed safely, are these procedures that could endanger public health?

"They have to protect the population," said Glen Spaulding, a xenotransplantation specialist at Tufts University. "It's getting more complicated very fast."

There are many trials going on right now, involving the treatment of a host of chronic illnesses. In fact, there are five companies harvesting pancreatic cells from pigs for use in islet transplants. Some companies are even creating cells by breeding animals with human genes.

"These things could take off very rapidly," Noguchi said. "We must be ready."

Noguchi said that there will be a time when doctors can mix and match cells, creating customized biological therapies for individual patients.


Categories: Food, Government & Policy, Insulin, Islet & Pancreas Transplant



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Sep 1, 1995

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.